Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome

OBJECTIVES: Dual antiplatelet therapy (DAPT), consisting of clopidogrel and aspirin, is the main-stay treatment of acute coronary syndromes (ACS). However, major adverse cardiovascular events may occur even in patients undergoing DAPT, and this has been related to the variable pharmacodynamic effica...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian J Pharmacol
Autors principals: Efe, Edem, Kocayiğit, Ibrahim, Türker, Pabuccu Mustafa, Murat, Küçükukur, Erkan, Alpaslan, Sedat, Taş, Alper, Çil, Necati, Aksoy Murat, Gökhan, Vural Mustafa, Bahri, Akdeniz
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4980920/
https://ncbi.nlm.nih.gov/pubmed/27756943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.186205
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars